Related Experiment Video
Updated: Sep 25, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Epstein-Barr virus antibodies in multiple sclerosis
Abstract:
Serum antibody titers to Epstein-Barr virus (EBV), an agent that persists in a latent form after the initial infection, were determined in 157 patients with multiple sclerosis and in 81 control subjects. Two patients (1.3%) and five control subjects (6.2%) lacked antibodies to EBV. In the subjects with antibodies, the prevalence of high titers (greater than or equal to 1:160) was significantly greater in patients, 69 (44.5%), than in control subjects, 22 (28.9%). The geometric mean titer of antibodies to EBV was significantly higher in patients, 107.0, than in control subjects, 77.1. There was no association between antibody titers and duration or activity of the disease. These findings further support the contention that patients with multiple sclerosis have a general aberration of the immunological system.
Insights
Patients with multiple sclerosis show higher Epstein-Barr virus (EBV) antibody titers compared to controls, suggesting a potential link and immune system dysregulation in MS patients.
Area of Science:
- Immunology
- Virology
- Neurology
Background:
- Epstein-Barr virus (EBV) establishes a lifelong latent infection.
- Multiple sclerosis (MS) is a chronic neurological disease with suspected immune system involvement.
Purpose of the Study:
- To investigate the association between serum antibody titers to Epstein-Barr virus (EBV) and multiple sclerosis (MS).
- To explore potential immune system aberrations in MS patients related to EBV infection.
Main Methods:
- Serum samples were collected from 157 MS patients and 81 healthy controls.
- Antibody titers to EBV were quantified using serological assays.
- Prevalence of high titers and geometric mean titers were compared between groups.
Main Results:
- A significantly higher prevalence of high EBV antibody titers (≥1:160) was observed in MS patients (44.5%) compared to controls (28.9%).
- The geometric mean EBV antibody titer was significantly elevated in MS patients (107.0) versus controls (77.1).
- No correlation was found between EBV antibody titers and MS disease duration or activity.
Conclusions:
- These findings support the hypothesis that individuals with MS exhibit altered immune responses.
- Elevated EBV antibody titers in MS patients may indicate a role for EBV in the disease pathogenesis or reflect a broader immunological abnormality.
Related Concept Videos
Cross-reactivity
Multiple Sclerosis l: Introduction

